Call Options Transactions Made in Q3 2024 in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN) during Q3 2024. The information is specifically focused on institutions that hold call options of Day One Biopharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
BUY
|
CALL |
30KNew |
$382K - $481K
|
30K
$406K
|
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
BUY
|
CALL |
29.9K+ 99.67% |
$380K - $479K
|
59.9K
$811K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-2.8K- 12.73% |
$35.6K - $44.9K
|
19.2K
$260K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-16.5K- 63.22% |
$210K - $264K
|
9.6K
$130K
|